TGF-β in Skin Cancer and Fibrosis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-4-431-54409-8_9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities

  2012cited by this paper
• MicroRNA Expression Abnormalities in Limited Cutaneous Scleroderma and Diffuse Cutaneous Scleroderma

  2012cited by this paper
• Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures.

  2012cited by this paper
• FK506 inhibits the enhancing effects of transforming growth factor (TGF)‐β1 on collagen expression and TGF‐β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach

  2012cited by this paper
• Innovative antifibrotic therapies in systemic sclerosis

  2012cited by this paper
• Transforming growth factor‐β enhances invasion and metastasis in Ras‐transfected human malignant epidermal keratinocytes

  2012cited by this paper
• Strategies for prevention of scars: what can we learn from fetal skin?

  2011cited by this paper
• New insights on chemically induced animal models of systemic sclerosis

  2011cited by this paper
• Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: From Animal Models to Clinical Trials

  2011cited by this paper
• Roles of TGFβ signaling Smads in squamous cell carcinoma

  2011cited by this paper
• Temporal smad7 transgene induction in mouse epidermis accelerates skin wound healing.

  2011cited by this paper
• Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.

  2011cited by this paper
• TGF-β inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1.

  2010cited by this paper
• Animal model of systemic sclerosis

  2010cited by this paper
• Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies

  2010cited by this paper
• Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis

  2010cited by this paper
• Mechanisms of skin fibrosis in systemic sclerosis

  2010cited by this paper
• Genetics of keloid scarring

  2010cited by this paper
• Epidermal Smad4 deletion results in aberrant wound healing.

  2010cited by this paper
• Animal models of scleroderma: fresh insights

  2010cited by this paper
• HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion.

  2010cited by this paper
• Scarless fetal wound healing: a basic science review.

  2010cited by this paper
• Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation.

  2009cited by this paper
• A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate

  2009cited by this paper
• Tumor suppressor and oncogene actions of TGFβ1 occur early in skin carcinogenesis and are mediated by Smad3

  2009cited by this paper
• Keloid scarring: new treatments ahead.

  2009cited by this paper
• Keloid scarring: bench and bedside

  2009cited by this paper
• Expression of Integrin αvβ6 and TGF-β in Scarless vs Scar-forming Wound Healing

  2009cited by this paper
• Smad4-dependent desmoglein-4 expression contributes to hair follicle integrity.

  2008cited by this paper
• Fibroblast-specific perturbation of transforming growth factor beta signaling provides insight into potential pathogenic mechanisms of scleroderma-associated lung fibrosis: exaggerated response to alveolar epithelial injury in a novel mouse model.

  2008cited by this paper
• Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate.

  2008cited by this paper
• Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression.

  2008cited by this paper
• Cutaneous two-stage chemical carcinogenesis.

  2007cited by this paper
• A role for TGF-beta1-induced cellular responses during wound healing of the non-scarring early human fetus?

  2007cited by this paper
• Roles of Smad3 in TGF-β Signaling During Carcinogenesis

  2007cited by this paper
• Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

  2007cited by this paper
• Systemic sclerosis: a prototypic multisystem fibrotic disorder.

  2007cited by this paper
• Distinct roles of individual Smads in skin carcinogenesis

  2007cited by this paper
• Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.

  2007cited by this paper
• Transforming Growth Factor-β Receptor Type I-dependent Fibrogenic Gene Program Is Mediated via Activation of Smad1 and ERK1/2 Pathways*

  2007cited by this paper
• Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia.

  2007cited by this paper
• Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2

  2007cited by this paper
• Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse.

  2006cited by this paper
• Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring.

  2006cited by this paper
• The early history of TGF-β, and a brief glimpse of its future

  2006cited by this paper
• Role of TGFβ in skin inflammation and carcinogenesis

  2006cited by this paper
• Role of TGFβ-Mediated Inflammation in Cutaneous Wound Healing

  2006cited by this paper
• Potential regulatory elements of the constitutive up-regulated alpha2(I) collagen gene in scleroderma dermal fibroblasts.

  2006cited by this paper
• A “traffic control” role for TGFβ3: orchestrating dermal and epidermal cell motility during wound healing

  2006cited by this paper
• Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin

  2006cited by this paper
• Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma

  2006cited by this paper
• Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.

  2005cited by this paper
• Smad3 signalling plays an important role in keloid pathogenesis via epithelial–mesenchymal interactions

  2005cited by this paper
• Activation of Key Profibrotic Mechanisms in Transgenic Fibroblasts Expressing Kinase-deficient Type II Transforming Growth Factor-β Receptor (TβRIIΔk)*

  2005cited by this paper
• Targeted disruption of Smad4 in mouse epidermis results in failure of hair follicle cycling and formation of skin tumors.

  2005cited by this paper
• Upregulation of transforming growth factor-β1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity

  2005cited by this paper
• Abrogation of Transforming Growth Factor-β Signaling by SMAD7 Inhibits Collagen Gel Contraction of Human Dermal Fibroblasts*

  2005cited by this paper
• Functional significance of Smad2 in regulating basal keratinocyte migration during wound healing.

  2005cited by this paper
• Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.

  2005cited by this paper
• Targeted Disruption of TGF-β/Smad3 Signaling Modulates Skin Fibrosis in a Mouse Model of Scleroderma

  2004cited by this paper
• The Roles of Smad2 and Smad3 in the Development of Chemically Induced Skin Tumors in Mice

  2004cited by this paper
• Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis

  2004cited by this paper
• Regulation of PDGF and its receptors in fibrotic diseases.

  2004cited by this paper
• Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts.

  2004cited by this paper
• Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis‐like skin disorder

  2004cited by this paper
• An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.

  2004cited by this paper
• Fetal Wound Healing: Current Biology

  2003cited by this paper
• Ontogenetic transition in fetal wound transforming growth factor-beta regulation correlates with collagen organization.

  2003cited by this paper
• Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice

  2003cited by this paper
• Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.

  2003cited by this paper
• Migration of human keratinocytes in plasma and serum and wound re-epithelialisation.

  2003cited by this paper
• Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor β (TGFβ) Receptor Leads to Paradoxical Activation of TGFβ Signaling Pathways with Fibrosis in Transgenic Mice*

  2003cited by this paper
• Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.

  2003cited by this paper
• Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.

  2002cited by this paper
• Development, characterization, and wound healing of the keratin 14 promoted transforming growth factor‐β1 transgenic mouse

  2002cited by this paper
• Deficient Smad7 expression: A putative molecular defect in scleroderma

  2002cited by this paper
• Progress in cutaneous cancer research.

  2002cited by this paper
• Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo.

  2002cited by this paper
• Resistance of keratinocytes to TGFbeta-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds.

  2002cited by this paper
• Ontogeny of Expression of Transforming Growth Factor-β1 (TGF-β1), TGF-β3, and TGF-β Receptors I and II in Fetal Rat Fibroblasts and Skin

  2001cited by this paper
• Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.

  2001cited by this paper
• Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma.

  2001cited by this paper
• Role of TGFβ signaling in skin carcinogenesis

  2001cited by this paper
• Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds.

  2001cited by this paper
• Healing of burn wounds in transgenic mice overexpressing transforming growth factor-beta 1 in the epidermis.

  2001cited by this paper
• Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation.

  2001cited by this paper
• TGF‐β isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis

  2000cited by this paper
• Synergistic Cooperation between Sp1 and Smad3/Smad4 Mediates Transforming Growth Factor β1 Stimulation of α2(I)-Collagen (COL1A2) Transcription*

  2000cited by this paper
• Incisional wound healing in transforming growth factor‐β1 null mice

  2000cited by this paper
• Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.

  1999cited by this paper
• Cutaneous wound healing.

  1999cited by this paper
• Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3.

  1999cited by this paper
• Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis.

  1999cited by this paper
• Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor β-Mediated Signal Transduction

  1999cited by this paper
• Genetic events and the role of TGFβ in epithelial tumour progression

  1999cited by this paper
• Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects.

  1999cited by this paper
• Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids.

  1999cited by this paper
• TGF-β: 20 years and counting

  1999cited by this paper
• Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β

  1999cited by this paper
• Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

  1999cited by this paper

• No citing papers are available for this paper.